Lynne Marie Sullivan Unity Biotechnology, Inc. (UBX) insider trading activity

Lynne Marie Sullivan is CFO & Head of Corp. Dev. of Unity Biotechnology, Inc.. Currently has a direct ownership of 98,905 shares of UBX, which is worth approximately $101,872. The most recent transaction as insider was on Apr 02, 2025, when has been sold 21,867 shares (Common Stock, $0.0001 par value) at a price of $1.03 per share, resulting in proceeds of $22,523. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 98.9K

76.85% 3M change

199.63% 12M change

Total Value Held $101,872

Lynne Marie Sullivan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 02 2025	SELL Open market or private sale	$22,523 $1.03 p/Share	21,867 Reduced 18.11%	98,905 Common Stock, $0.0001 ...
Mar 28 2025	BUY Grant, award, or other acquisition	-	65,000 Added 34.99%	120,772 Common Stock, $0.0001 ...
Feb 04 2025	SELL Open market or private sale	$341 $2.23 p/Share	153 Reduced 0.27%	55,772 Common Stock, $0.0001 ...
Nov 04 2024	SELL Open market or private sale	$175 $1.29 p/Share	136 Reduced 0.24%	55,925 Common Stock, $0.0001 ...
Aug 02 2024	SELL Open market or private sale	$212 $1.53 p/Share	139 Reduced 0.25%	56,061 Common Stock, $0.0001 ...
Jun 25 2024	SELL Open market or private sale	$453 $1.4 p/Share	324 Reduced 0.98%	32,685 Common Stock, $0.0001 ...
May 15 2022	BUY Other acquisition or disposition	$6,373 $6.89 p/Share	925 Added 2.73%	33,009 Common Stock, $0.0001 ...
Feb 09 2022	BUY Grant, award, or other acquisition	-	50,000 Added 13.27%	326,785 Common Stock, $0.0001 ...
Jun 24 2021	BUY Grant, award, or other acquisition	-	30,833 Added 10.22%	270,833 Common Stock, $0.0001 ...

Also insider at

PHGE

BiomX Inc. Healthcare

Director

SLDB

Solid Biosciences Inc. Healthcare

INZY

Inozyme Pharma, Inc. Healthcare

LMS